Will SMMT insiders remain net buyers (zero dispositions) through H1 2026?
Current Prediction
Why This Question Matters
Insiders have shown unprecedented alignment with zero sales and massive PIPE participation. Any insider selling ahead of the PDUFA date would be a sharp departure from this pattern and could signal reduced conviction in approval prospects. Continued buying would reinforce the bullish thesis.
Prediction Distribution
Individual Predictions(9 runs)
The pattern of zero sales over 10 months, combined with open market purchases and massive PIPE participation, represents extraordinary conviction. With the PDUFA date in November 2026, insiders have strong incentive to maintain the zero-selling pattern through H1 to avoid negative signaling ahead of the most important catalyst. Selling before PDUFA data would be strategically irrational.
The zero-selling pattern is remarkable but not guaranteed to continue. Minor transactions — gifts, tax-related sales, estate planning — could technically trigger a NO resolution. Board members other than the co-CEOs hold smaller positions and may have different personal financial needs. The question includes ALL insiders, not just the co-CEOs.
No 10b5-1 plans are in place, which means any sales would be deliberate and visible. The co-CEOs control 76% and would not sell ahead of PDUFA. The smaller insiders (Soni, Anand) have relatively small positions and are more likely to hold. Xia Yu (Akeso) has minimal SMMT shares. Main risk is a board member gifting or donating shares.
Insiders have demonstrated conviction with both their wallets (purchases) and their restraint (zero sales). With the PDUFA catalyst ahead, selling would be the worst possible signal. The concentrated ownership means even small sales would be headline news. No rational insider would sell before the November catalyst unless they knew something negative.
The 3.5-month window (March-June) is short, which favors YES. However, the question demands ZERO dispositions. Any form 4 showing any insider disposing of shares in any form resolves NO. Tax planning, charitable giving, even inadvertent reporting could trigger it. The strict standard makes this harder than it appears.
The incentive structure strongly favors continued zero selling. Insiders bought in at $18.74 (PIPE) and $17-18 (open market). Selling below those levels would be realizing losses. Selling above would undermine the narrative. The equilibrium favors holding through PDUFA. Only unexpected personal financial distress or a material negative data leak would change the calculus.
Strong pattern of zero sales. PDUFA ahead. No incentive to sell. Short window. High probability of continued zero dispositions.
Zero dispositions is a strict standard. Minor technical transactions (gifts, tax) could trigger NO. But core insider behavior strongly favors continued holding.
Insider conviction is real and PDUFA incentive is strong. Expect continued zero-selling pattern through H1 2026.
Resolution Criteria
Resolves YES if no Summit insider (officers or directors) files a Form 4 reporting any disposition (sale, gift, or other disposal) of SMMT common stock through June 30, 2026. Resolves NO if any insider disposes of shares by that date.
Resolution Source
SEC EDGAR Form 4 filings for Summit Therapeutics
Source Trigger
Insider transaction activity — monitoring for first insider sales or continued buying
Full multi-lens equity analysis